Nanosonics Ltd has released a press release.
US FDA clearance received for next generation trophon
Filed with ASX ·
Watch Nanosonics' latest callNanosonics (ASX:NAN) Q2 2026 Earnings Call · Replay · Feb 23Read the transcript of Nanosonics (ASX:NAN) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Story so far
Earlier from Nanosonics
- Nanosonics launches trophon3 and trophon2 Plus software
- Response to ASX Price Query
- Nanosonics Receives FDA De Novo Clearance for CORIS
- 2025 Half Year Financial Results
- Appendix 4D and Half Year Accounts
Later from Nanosonics
- Appendix 4E
- Nanosonics to commence $20 million share buy-back program
- 2026 Full Year Financial Results
- Appointment of Non-Executive Director
- 2026 Annual General Meeting Presentation
Follow Nanosonics into a list and get an email when it puts out news.
Follow Nanosonics